Investment accounts
Adult accounts
Child accounts
Choosing Fidelity
Choosing Fidelity
Why invest with us Current offers Fees and charges Open an account Transfer investments
Financial advice & support
Fidelity’s Services
Fidelity’s Services
Financial advice Retirement Wealth Management Investor Centre (London) Bereavement
Guidance and tools
Guidance and tools
Choosing investments Choosing accounts ISA calculator Retirement calculators
Share dealing
Choose your shares
Tools and information
Tools and information
Share prices and markets Chart and compare shares Stock market news Shareholder perks
Pensions & retirement
Pensions, tax & tools
Saving for retirement
Approaching / In retirement
Approaching / In retirement
Speak to a specialist Creating a retirement plan Taking tax-free cash Pension drawdown Annuities Investing in retirement Investment Pathways
London midday: Stocks stay up but Reckitt tanks on litigation concerns
(Sharecast News) - London stocks were still in the black by midday on Monday as investors eyed a week jam-packed with earnings releases and the latest policy announcements from the Federal Reserve and the Bank of England.
The FTSE 100 was up 0.9% at 8,358.12.
Richard Hunter, head of markets at Interactive Investor, said earnings season was set to be "at full throttle" in the UK this week.
"Updates from BP and Shell will be among the highlights, in addition to releases from the likes of Diageo, Next, International Consolidated Airlines and Rolls-Royce," he said.
"For the banks, HSBC, Standard Chartered and Barclays will round off the season, hoping to repeat the strong lead given so far from Lloyds Banking and NatWest, where creditable half-year performances were boosted by a strong second quarter.
"There will also be some focus on the Bank of England, which will reveal its latest interest rate decision on Thursday. At present, the consensus is evenly split between a cut and a no-change decision, with the latest economic data having seemingly been unbale to provide a definitive steer. A cut at some point this year is nevertheless expected, although the timing remains on the flip of a coin."
Investors were mulling the latest data from the Bank of England, which showed that mortgage approvals fell marginally in June as the upwards momentum seen earlier in the year year continues to tail off, though there are signs that the housing market is beginning to stabilise.
Net mortgage approvals for house purchases slipped to 59,976 last month, down slightly from the 60,134 recorded in May.
Approvals have declined since March, when they reached 61,080 - their highest since September 2022. However, last month's figure remains significantly higher than the 53,620 recorded in June 2023. Meanwhile, approvals for remortgaging fell to 27,500 from 29,300 the month before.
Individuals borrowed a net £2.7bn for mortgages in June, nearly double the £1.3bn borrowed in May.
The BoE also announced that net consumer credit borrowing fell slightly in June to £1.2bn, from £1.5bn in May, with the annual growth of consumer credit easing to 8.0% from 8.4%.
Investors were also eyeing a statement to Parliament on Monday afternoon by Chancellor Rachel Reeves, who is expected to reveal cuts to plug a £20bn black hole in public finances.
In equity markets, oil giants BP and Shell both gushed higher as oil prices nudged up. "Oil prices had been on a downward trend since early July, so finding price stability has offered some reassurance," said Dan Coatsworth, investment analyst at AJ Bell.
Elsewhere, consumer goods firm Reckitt Benckiser tumbled amid potential litigation concerns, after a US jury found on Friday that infant formula by Abbott Laboratories had caused a girl to develop a serious bowel disease. Abbott was ordered to pay $495m in damages.
AJ Bell's Coatsworth said: "Reckitt's shares have been severely depressed since March as the market worries about the scale of any potential liabilities if the company loses legal battles around the safety of its baby formula.
"A US court case has already awarded $60 million in damages to a mother who said her baby died after consuming Reckitt's Enfamil baby formula. Several hundred similar claims have been in filed in US courts targeting Reckitt and Abbott.
"The more setbacks for either baby formula maker, the more complicated it becomes for Reckitt to sell its nutrition arm. Reckitt last week indicated it might be up for sale, saying it was considering all options for the business.
"Any potential buyer could be put off by the possibility of liabilities from the court cases, meaning the pressure is growing for Reckitt to find a way to ringfence a large amount of money in case it loses big time in the court battles."
Educational publisher Pearson nudged down despite saying it delivered a "solid" performance in the first half, with underlying sales and profits ahead of last year, as it reiterated its outlook for the next two years.
Entain fell as it said that BetMGM, its sports betting and iGaming operator in the US, surpassed the $1bn mark for revenues in the first half, but still made a loss as a result of heavy investments during the period.
Market Movers
FTSE 100 (UKX) 8,358.12 0.87% FTSE 250 (MCX) 21,450.63 0.44% techMARK (TASX) 4,857.03 0.70%
FTSE 100 - Risers
SEGRO (SGRO) 923.20p 3.50% Airtel Africa (AAF) 113.30p 3.19% NATWEST GROUP (NWG) 370.80p 2.46% JD Sports Fashion (JD.) 126.10p 2.23% Prudential (PRU) 700.20p 2.22% Unite Group (UTG) 955.50p 2.19% Centrica (CNA) 133.10p 2.19% Barclays (BARC) 236.30p 2.12% Land Securities Group (LAND) 641.00p 1.99% 3i Group (III) 3,088.00p 1.98%
FTSE 100 - Fallers
Reckitt Benckiser Group (RKT) 4,057.00p -9.56% Entain (ENT) 599.20p -7.67% Flutter Entertainment (DI) (FLTR) 15,155.00p -1.27% International Consolidated Airlines Group SA (CDI) (IAG) 165.60p -0.93% Fresnillo (FRES) 574.00p -0.86% Anglo American (AAL) 2,370.00p -0.71% F&C Investment Trust (FCIT) 1,038.00p -0.38% Diageo (DGE) 2,556.00p -0.37% Whitbread (WTB) 2,887.00p -0.31% Coca-Cola HBC AG (CDI) (CCH) 2,840.00p -0.21%
FTSE 250 - Risers
W.A.G Payment Solutions (WPS) 66.80p 4.05% Me Group International (MEGP) 191.60p 3.34% Cranswick (CWK) 4,680.00p 3.08% PureTech Health (PRTC) 181.80p 2.83% Bridgepoint Group (Reg S) (BPT) 281.60p 2.77% IP Group (IPO) 41.80p 2.58% Great Portland Estates (GPE) 355.50p 2.30% Direct Line Insurance Group (DLG) 191.80p 2.29% Safestore Holdings (SAFE) 806.50p 2.22% Tritax Big Box Reit (BBOX) 166.90p 2.14%
FTSE 250 - Fallers
Energean (ENOG) 1,046.00p -4.47% Indivior (INDV) 963.00p -2.43% NB Private Equity Partners Ltd. (NBPE) 1,700.00p -2.30% Man Group (EMG) 253.80p -2.16% Aston Martin Lagonda Global Holdings (AML) 160.30p -2.14% HGCapital Trust (HGT) 518.00p -2.08% Inchcape (INCH) 844.50p -1.97% Pagegroup (PAGE) 424.40p -1.90% Patria Private Equity Trust (PPET) 556.00p -1.77% Genus (GNS) 1,814.00p -1.73%
Share this article
Related Sharecast Articles
Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.
Award-winning online share dealing
Search, compare and select from thousands of shares.
Expert insights into investing your money
Our team of experts explore the world of share dealing.
Policies and important information
Accessibility | Conflicts of interest statement | Consumer Duty Target Market | Consumer Duty Value Assessment Statement | Cookie policy | Diversity, Equity & Inclusion | Doing Business with Fidelity | Diversity, Equity & Inclusion Reports | Investing in Fidelity funds | Legal information | Modern slavery | Mutual respect policy | Privacy statement | Remuneration policy | Staying secure | Statutory and Regulatory disclosures | Whistleblowing programme
Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. This website does not contain any personal recommendations for a particular course of action, service or product. You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. Prior to investing into a fund, please read the relevant key information document which contains important information about the fund.
This website is issued by Financial Administration Services Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FCA Register number 122169) and registered in England and Wales under company number 1629709 whose registered address is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth, Surrey, KT20 6RP.